|
MED27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62241999999146E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.205500E-04 |
| Normal-vs-Stage2 |
1.930420E-02 |
| Normal-vs-Stage3 |
2.08559999999025E-05 |
| Normal-vs-Stage4 |
6.443000E-03 |
| Stage1-vs-Stage2 |
7.310400E-01 |
| Stage1-vs-Stage3 |
1.419370E-01 |
| Stage1-vs-Stage4 |
7.248600E-01 |
| Stage2-vs-Stage3 |
6.293600E-01 |
| Stage2-vs-Stage4 |
9.625800E-01 |
| Stage3-vs-Stage4 |
5.268600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07730000001405E-06 |
| Normal-vs-AfricanAmerican |
4.236200E-01 |
| Normal-vs-Asian |
2.795200E-01 |
| Caucasian-vs-AfricanAmerican |
1.099840E-02 |
| Caucasian-vs-Asian |
6.255600E-01 |
| AfricanAmerican-vs-Asian |
5.732200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56030999999279E-05 |
| Normal-vs-Female |
5.953300E-04 |
| Male-vs-Female |
2.631600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.724780E-01 |
| Normal-vs-Age(41-60Yrs) |
7.75400000000426E-05 |
| Normal-vs-Age(61-80Yrs) |
4.6820000000336E-06 |
| Normal-vs-Age(81-100Yrs) |
4.710600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.108400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.968640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.948400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.965600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.255200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.340400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.336800E-01 |
| Normal-vs-Grade 2 |
2.632600E-04 |
| Normal-vs-Grade 3 |
9.06390000054991E-07 |
| Normal-vs-Grade 4 |
2.225900E-02 |
| Grade 1-vs-Grade 2 |
3.814400E-01 |
| Grade 1-vs-Grade 3 |
2.580400E-01 |
| Grade 1-vs-Grade 4 |
5.165800E-01 |
| Grade 2-vs-Grade 3 |
1.410040E-01 |
| Grade 2-vs-Grade 4 |
9.315200E-01 |
| Grade 3-vs-Grade 4 |
3.466400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.62769994652245E-09 |
| Normal-vs-ccB subtype |
6.781700E-03 |
| ccA subtype-vs-ccB subtype |
2.971700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.160490E-04 |
| Normal-vs-N1 |
7.356400E-02 |
| N0-vs-N1 |
8.861800E-01 |
|
|
